4//SEC Filing
Byam Rebecca 4
Accession 0001209191-24-003782
CIK 0001828673other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 2:19 PM ET
Size
4.9 KB
Accession
0001209191-24-003782
Insider Transaction Report
Form 4
Byam Rebecca
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-20$1.40/sh+760,714$1,065,000→ 1,381,909 total
Footnotes (1)
- [F1]The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866256
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 2:19 PM ET
- Size
- 4.9 KB